Fusions and method for detecting same
It is intended to reveal a polynucleotide serving as a novel causative gene of a cancer and, on the basis of this finding, to provide a method for detecting the polynucleotide or a polypeptide encoded thereby, a kit and a primer set for the detection, a method for screening for a substance that inhibits the polypeptide, and a pharmaceutical composition for the treatment of a cancer, containing the inhibiting substance. The detection method of the present invention detects a BRAF fusion protein or a fusion gene encoding the fusion protein, or a PXN or GMDS fusion protein or a fusion gene encoding the fusion protein in a digestive organ-derived sample obtained from a subject.
1. A kit for detecting a PXN-BRAF fusion gene in a sample obtained from a subject, the kit comprising sense and antisense primers designed to be capable of specifically amplifying a polynucleotide encoding a polypeptide which is a fusion protein of the PXN protein with the BRAF protein,
wherein the sense primer consists of an oligonucleotide of at least 16 consecutive nucleotides arbitrarily selected from nucleotide positions 1 to 962 of SEQ ID NO: 1, and the antisense primer consists of an oligonucleotide complementary to an oligonucleotide of at least 16 consecutive nucleotides arbitrarily selected from nucleotide positions 963 to 2067 of SEQ ID NO: 1.
2. A method for detecting a PXN fusion gene encoding a fusion protein in a sample obtained from a subject, the method comprising detecting the PXN-BRAF fusion gene using the kit according to claim 1 , wherein the sample is DNA or mRNA.
3. The method according to claim 2 , wherein the sample is a digestive organ-derived sample.